J. Hiscott
Molecular Oncology Group, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote. St. Catherine, Montreal, H3T 1E2, Canada
fax: +1 514 340 7576
email: john.hiscott@mcgill.ca

C. Basilico, NYU Medical Center, New York, NY, USA

M.V. Chao, Cornell University, New York, NY, USA

S.J. Durum, National Cancer Institute, Frederick, MD, USA

M. Feldmann, The Mathilda & Terence Kennedy Institute of Rheumatology, London, UK

T. Fujita, Kyoto University, Japan

A. Garcia-Sastre, Mount Sinai School of Medicine, New York, USA

C.-H. Heldin, Ludwig Institute Cancer Research, Uppsala, Sweden

T. Hirano, Osaka University Medical School, Osaka, Japan

C. Horvath, Northwestern University, Illinois, USA

J. Keski-Oja, University of Helsinki, Helsinki, Finland

M. Krönke, Institut für Immunologie, Kiel, Germany

W.J. Leonard, National Institutes of Health, Bethesda, MD, USA

L. O'Neill, School of Biochemistry, Trinity College Dublin, Ireland, UK

J.J. Oppenheim, National Cancer Institute, Frederick, MD, USA

R.W. Padgett, Rutgers University, Piscataway, NJ, USA

S. Pestka, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA

K. Pfizenmaier, Institute für Zellbiologie und Immunologie, Stuttgart, Germany

H.A. Reddi, University of California Davis Medical Center, Sacramento, CA, USA

C. Schindler, Columbia University, New York, USA

J. Schlessinger, Yale University School of Medicine,, New Haven, CT, USA

M. Sporn, Dartmouth Medical School, Hanover, USA

G. Trinchieri, Schering-Plough Lab of Immunological Research, Dardilly, France

J. Van Damme, Katholieke Universiteit, Rega Instituut, Leuven, Belgium

J. Vilcek, NYU Medical Center, New York. USA

S. Wahl, National Institutes of Health, Bethesda, MD, USA

D. Wallach, The Weizmann Institute of Science, Rehovot, Israel

C.F. Ware, La Jolla Institute for Allergy & Immunology, San Diego, CA, USA

B. Williams, Monash Institute of Medical Research, Australia

H. Young, National Cancer Institute - Frederick, Maryland, USA